Annual Drug Patent Expirations for LUMASON
Lumason is a drug marketed by Bracco and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has eleven patent family members in ten countries.
The generic ingredient in LUMASON is sulfur hexafluoride lipid-type a microspheres. One supplier is listed for this compound. Additional details are available on the sulfur hexafluoride lipid-type a microspheres profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com